Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism.
about
Hormone therapy for preventing cardiovascular disease in post-menopausal womenMenopause, hormone therapy and diabetes.Ospemifene's effects on lipids and coagulation factors: a post hoc analysis of phase 2 and 3 clinical trial data.Estrogen receptor alpha regulates expression of the orphan receptor small heterodimer partner.Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.Low-dose hormone replacement therapy: effects on bone.Effect of hormone replacement therapy on cardiovascular disease: current opinion.Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes.Vascular effects of estrogenic menopausal hormone therapy.The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trialHormone therapy and Alzheimer's disease: benefit or harm?Hormone replacement therapy and cardiovascular disease: lessons from a monkey model of postmenopausal women.Sex hormones, insulin sensitivity, and diabetes mellitus.Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy.Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials.Progestogen safety and tolerance in hormonal replacement therapy.Biochemical markers surrogating on vascular effects of sex steroid hormones.Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention StudyMeta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women.Vascular and metabolic effects of sex steroids: new insights into clinical trials.Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007.Differential effects of various progestogens on metabolic risk factors for breast cancer.Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combinationA new approach to menopausal therapy: the tissue selective estrogen complex.Estrogen dose: the cardiovascular impact.Drugs for the treatment of menopausal symptoms.Preventing osteoporosis with a tissue selective estrogen complex (TSEC) containing bazedoxifene/conjugated estrogens (BZA/CE).Conjugated estrogen/bazedoxifene tablets for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.Effect of menopausal hormone therapy on components of the metabolic syndrome.Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications.Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.Global profiling of TSEC proliferative potential by the use of a reporter mouse for proliferation.Estrogens and women's health: a scary or a fairy tale?Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women.Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause.Risk stratification of CAD with SPECT-MPI in women with known estrogen status.Effects of drospirenone on cardiovascular markers in human aortic endothelial cells.Psychological effects of tibolone and sequential estrogen-progestogen therapy in perimenopausal women.Herba Epimedii water extract elevates estrogen level and improves lipid metabolism in postmenopausal women.The effects of progesterones on blood lipids in hormone replacement therapy.
P2860
Q24187326-191E8BAF-25DA-441D-B837-830CC01FD2C9Q30239769-6D9C9669-957C-4C18-8EE8-CEA4ED6F67FEQ30491704-35C678E0-7478-43CB-8060-74E7F7AC83D5Q34211558-213FABB1-0530-42B2-AAB5-1AD4187DC5BEQ34375771-45088DA9-C654-419C-8B02-9F2CC49E863DQ34672074-FA556C70-720B-4643-BCC8-7AC6F9972B84Q35124691-A2412693-2BEA-4AB2-AF7E-3108705FD222Q35243693-1D8F504E-4314-4FDE-BFF6-EF1E3466E16BQ35583311-B55E2317-3E23-4F9D-A828-D5456B7532A6Q35602242-3C83386A-895F-428B-AC14-D8766F3EB11DQ35680612-BCD302F0-2FF1-4F4C-B5F6-CBB0CB6FDE97Q35757554-D0468E5A-BFBE-4D4E-83D9-3D224351D048Q35757562-AE320C55-4CD7-4593-91CA-44CBDD5DBB2AQ35885187-3A447CFF-D00F-48CB-AC46-9DF972277B86Q36086159-4A1C857A-155A-43DE-883A-189F6EB79494Q36109111-7760BB9A-EEC1-41C7-8B8D-1A9C0A7B7521Q36533649-4EAB83FD-C6A7-48D0-853F-8438D44692D4Q36537470-D23E9184-75C0-4392-A998-0A9AD773FF43Q36570589-04919476-111F-47F9-A3A2-0B87D86A6BF2Q36888620-DAC06D7F-FDF3-474B-81BE-DBD644233A2DQ36970351-2189C255-E4B0-42BE-A4D0-DA179E5B062FQ36974417-B43801F2-CE14-401B-84C1-D7A61D16AC46Q37095740-A14886C3-F69D-4BBA-8D02-EF272588D91EQ37352516-30C7C32F-E6E5-468B-AC11-B2D9EB962C8FQ37610405-DF86F4AC-059E-4BC9-863E-3CF6C68B56BDQ37735189-B7C743D1-A17C-469C-B396-912DB5F85E12Q37808639-9FA04C6C-899D-4D3C-BB94-F228A52F20E1Q38193873-D6FBB2FB-FACC-4622-AEFF-4ACE1C5D00F9Q38846337-D38F343D-A7D7-4272-A3B0-69BB41DFAEB5Q39190439-12A8DD43-AA2C-47DF-B4AD-14400CFEC5E6Q40496635-7D8005A1-D456-4A29-B33A-34ABCAB4EF1AQ43715217-E929E194-DB87-45CD-922D-AA47A7753FAEQ43801855-614F5ADD-0B81-4E21-9728-3B808BA5BA83Q44563404-9A5F05ED-6F0F-4BAA-98FB-9D40727AA79FQ45219310-1098F9C4-A5FF-4024-8E07-03E16CC30739Q45823545-CB572764-9BD3-435F-888A-9A9AC80C2577Q46268406-6BFB820E-1F7A-4BCB-877C-E736BCCBD26BQ46432698-A360DE00-5F6E-4E84-A3C3-EC8B91604100Q46433877-AE442D23-4403-440C-9076-5D5E46D9B8F6Q47102333-338EA738-DE4F-4656-9F8D-23C18D8C933E
P2860
Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Effects of lower doses of conj ...... , and carbohydrate metabolism.
@en
Effects of lower doses of conj ...... , and carbohydrate metabolism.
@nl
type
label
Effects of lower doses of conj ...... , and carbohydrate metabolism.
@en
Effects of lower doses of conj ...... , and carbohydrate metabolism.
@nl
prefLabel
Effects of lower doses of conj ...... , and carbohydrate metabolism.
@en
Effects of lower doses of conj ...... , and carbohydrate metabolism.
@nl
P2093
P1476
Effects of lower doses of conj ...... , and carbohydrate metabolism.
@en
P2093
P356
10.1016/S0015-0282(01)01829-5
P407
P577
2001-07-01T00:00:00Z